284 related articles for article (PubMed ID: 25726059)
21. [Pancreatic carcinoma. Optimizing therapy by adjuvant and neoadjuvant therapy?].
Maurer CA; Zgraggen K; Büchler MW
Zentralbl Chir; 1999; 124(5):401-7. PubMed ID: 10420525
[TBL] [Abstract][Full Text] [Related]
22. The Multidisciplinary Approach to Localized Pancreatic Adenocarcinoma.
Parekh HD; Starr J; George TJ
Curr Treat Options Oncol; 2017 Nov; 18(12):73. PubMed ID: 29143898
[TBL] [Abstract][Full Text] [Related]
23. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
24. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma.
Winner M; Goff SL; Chabot JA
Semin Oncol; 2015 Feb; 42(1):86-97. PubMed ID: 25726054
[TBL] [Abstract][Full Text] [Related]
26. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
[TBL] [Abstract][Full Text] [Related]
27. The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
Brunner TB; Scott-Brown M
Radiat Oncol; 2010 Jul; 5():64. PubMed ID: 20615227
[TBL] [Abstract][Full Text] [Related]
28. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
29. New developments in the management of borderline resectable pancreatic cancer.
Sharma J; Ng J; Goodman MD; Saif MW
JOP; 2013 Mar; 14(2):123-5. PubMed ID: 23474551
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant treatment of surgically resectable pancreatic ductal adenocarcinoma.
Tesfaye AA; Philip PA
Clin Adv Hematol Oncol; 2019 Jan; 17(1):54-63. PubMed ID: 30843899
[TBL] [Abstract][Full Text] [Related]
31. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
[TBL] [Abstract][Full Text] [Related]
33. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma.
Abrams RA
Cancer J; 2012; 18(6):624-32. PubMed ID: 23187851
[TBL] [Abstract][Full Text] [Related]
34. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
35. Optimal timing and treatment strategy for pancreatic cancer.
Gamboa AC; Rupji M; Switchenko JM; Lee RM; Turgeon MK; Meyer BI; Russell MC; Cardona K; Kooby DA; Maithel SK; Shah MM
J Surg Oncol; 2020 Sep; 122(3):457-468. PubMed ID: 32470166
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
37. [Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].
Deberne M; Huguet F; Le Scodan R; Hammel P; Andre T
Bull Cancer; 2007 Jan; 94(1):72-80. PubMed ID: 17237007
[TBL] [Abstract][Full Text] [Related]
38. Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.
Kang CM; Hwang HK; Choi SH; Lee WJ
Surg Oncol; 2013 Jun; 22(2):123-31. PubMed ID: 23518243
[TBL] [Abstract][Full Text] [Related]
39. Rationale and appropriate use of chemotherapy and radiotherapy for pancreatic ductal adenocarcinoma.
Marsh Rde W; George T
Curr Gastroenterol Rep; 2006 Apr; 8(2):111-20. PubMed ID: 16533473
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant and neoadjuvant treatment in pancreatic cancer.
Herreros-Villanueva M; Hijona E; Cosme A; Bujanda L
World J Gastroenterol; 2012 Apr; 18(14):1565-72. PubMed ID: 22529684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]